Over 400 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
25 presentations, case studies and panel discussions focused on the key issues in follow-on biologics development and commercialisation
2 interactive streams:
- Market Opportunities and Commercial Challenges
- Developing Biosimilars and Biobetters
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities
Co-located with the 7th Annual Proteins & Antibodies Congress & the Peptides Congress Oxford Global are proud to present the Biosimilars & Biobetters Congress, taking place on 3-4 April 2014 at Novotel London West, UK.
The follow on biologics industry is forecast to reach $8.8 billion by 2017. Our conference programme focuses on the challenges, innovations and technologies that promise to put this sector at the forefront of the pharmaceutical industry.
The 2nd Annual Biosimilars and Biobetters Congress features two streams:
Market Opportunities & Commercial Challenges: In Stream 1, the meeting will discuss key strategies for overcoming regulatory challenges, gaining access to emerging markets and commercialising biosimilars. The programme also covers the leading advancements in substitution and interchangeability of biosimilars.
Developing Biosimilars & Biobetters: Learn more about current developments in clinical trials, including pharmacovigilence and patient safety. Our internationally renowned speakers will also explore the critical issues in developing biosimilars, including achieving quality by design and demonstrating biosimilarity. Do not miss out on hearing the latest insights into regulatory requirements and trial design.
The Biosimilars & Biobetters Congress is part of the highly successful Oxford Global Proteins Series. For more information on other events in the series, please see below: